tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andy Hsieh, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst Andy Hsieh, currently employed at WILLIAM BLAIR, carries an average stock price target met ratio of 100% that have a potential upside of 13.74% achieved within 57 days.
Andy Hsieh’s has documented 5 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on FGEN, FibroGen at 26-Jun-2023.
Analyst best performing recommendations are on FGEN (FIBROGEN).
The best stock recommendation documented was for FGEN (FIBROGEN) at 8/8/2017. The price target of $56.3 was fulfilled within 57 days with a profit of $6.8 (13.74%) receiving and performance score of 2.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$2
$0.84 (72.41%)
$4
1 years 5 months 7 days ago
(08-Aug-2023)
2/7 (28.57%)
$0.56 (38.89%)
133
Sell
$2
$0.84 (72.41%)
$16
1 years 6 months 19 days ago
(27-Jun-2023)
9/10 (90%)
$-0.51 (-20.32%)
140
Hold
$11
$9.84 (848.28%)
1 years 6 months 20 days ago
(26-Jun-2023)
1/6 (16.67%)
$8.29 (305.90%)
389
Hold
$35
1 years 6 months 20 days ago
(26-Jun-2023)
2/4 (50%)
$12.89 (58.30%)
15
Hold
$3
$1.84 (158.62%)
$25
1 years 6 months 20 days ago
(26-Jun-2023)
2/4 (50%)
$0.29 (10.70%)
127
What Year was the first public recommendation made by Andy Hsieh?
